Promoter Jay Arvind Bhanushali Acquires Shares in Aspira Pathlab & Diagnostics
Aspira Pathlab & Diagnostics Ltd 路 Acquisition/ Disposal of Shares 路 01 Oct 2026, 3:56 pm
Promoter Jay Arvind Bhanushali Acquires Shares in Aspira Pathlab & Diagnostics Promoter Jay Arvind Bhanushali acquired 245 equity shares (0.002% voting capital) of Aspira Pathlab & Diagnostics Ltd via open market purchases on 28th Sep'26. Following the transaction, Bhanushali's direct shareholding increased from 7,49,262 equity shares to 7,49,507 equity shares, maintaining a 7.28% stake in the total voting and diluted share capital. The company鈥檚 overall equity base remains unchanged at 1,02,93,000 equity shares of Rs. 10 each, aggregating to Rs. 10.29 crore.
Original exchange filing (PDF)
More announcements from Aspira Pathlab & Diagnostics Ltd
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali 路 18 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali 路 14 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali 路 14 Nov 2026
- Enclosed herewith Financial Result for the Half Year ended 30th September 2026 路 06 Nov 2026
- Enclosed herewith Board Meeting Outcomes dated 6th November 2026 路 06 Nov 2026
- Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2026 ,inter alia, to consider and approve Un-audited Financial .... 路 06 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali 路 28 Sept 2026
- Disclosure of Voting Results of 53rd Annual General Meeting along with the Scrutinizer Report 路 26 Sept 2026
